Literature DB >> 2887970

Pathogenesis of haemolytic uraemic syndrome.

T G Obrig, P J Del Vecchio, M A Karmali, M Petric, T P Moran, T K Judge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2887970     DOI： 10.1016/s0140-6736(87)92473-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

1.  Specific targeting of tumor endothelial cells by a shiga-like toxin-vascular endothelial growth factor fusion protein as a novel treatment strategy for pancreatic cancer.

Authors:  Birgit Hotz; Marina V Backer; Joseph M Backer; Heinz-J Buhr; Hubert G Hotz
Journal:  Neoplasia       Date:  2010-10       Impact factor: 5.715

2.  Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide.

Authors:  T Waddell; A Cohen; C A Lingwood
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

Review 3.  Glomerular fibrin deposition and removal.

Authors:  J M Bergstein
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

Review 4.  New insights into the haemolytic uraemic syndromes.

Authors:  D V Milford; C M Taylor
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

Review 5.  Current views on aetiology and management of haemolytic uraemic syndrome.

Authors:  M M Fitzpatrick; M J Dillon
Journal:  Postgrad Med J       Date:  1991-08       Impact factor: 2.401

6.  Shiga toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factors that stimulate platelet function.

Authors:  Fadila Guessous; Marek Marcinkiewicz; Renata Polanowska-Grabowska; Sudawadee Kongkhum; Daniel Heatherly; Tom Obrig; Adrian R L Gear
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 7.  Causes of the haemolytic uraemic syndrome.

Authors:  J Kavi; R Wise
Journal:  BMJ       Date:  1989-01-14

Review 8.  The shigella paradigm and colitis due to enterohaemorrhagic Escherichia coli.

Authors:  D W Acheson; G T Keusch
Journal:  Gut       Date:  1994-07       Impact factor: 23.059

Review 9.  Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes.

Authors:  B S Kaplan; T G Cleary; T G Obrig
Journal:  Pediatr Nephrol       Date:  1990-05       Impact factor: 3.714

10.  Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro.

Authors:  C B Louise; T G Obrig
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.